Reducing Atrial Pacing Rate to Reduce Atrial Fibrillation in Patients With Sick Sinus Syndrome.

NCT02034526 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 540

Last updated 2024-02-08

No results posted yet for this study

Summary

Atrial fibrillation (AF) is prevalent in patients with sick sinus syndrome (SSS) and associated with an increased risk of stroke and death. Within the first two years after pacemaker implantation almost half of the patients are diagnosed with AF. Studies have indicated that an increased amount of stimulation from the pacemaker in the atria is associated with an increased amount of AF.

The aim of the present study is to test the hypothesis that a reduction of stimulation from the pacemaker in the atria, and reducing the minimal heart rate, increases the time to AF.

Conditions

Interventions

DEVICE

DDDR-60

DDDR, lower pacing rate 60 bpm, RR activated (low-moderate)

DEVICE

DDD-40

DDD, lower pacing rate 40 bpm, RR function off

Sponsors & Collaborators

  • Aalborg University Hospital

    collaborator OTHER
  • Herning Hospital

    collaborator OTHER
  • Regionshospitalet Viborg, Skive

    collaborator OTHER
  • Aabenraa Hospital

    collaborator OTHER
  • Esbjerg Hospital - University Hospital of Southern Denmark

    collaborator OTHER
  • Vejle Hospital

    collaborator OTHER
  • Odense University Hospital

    collaborator OTHER
  • Zealand University Hospital

    collaborator OTHER
  • Rigshospitalet, Denmark

    collaborator OTHER
  • Bispebjerg Hospital

    collaborator OTHER
  • University Hospital, Gentofte, Copenhagen

    collaborator OTHER
  • Hillerod Hospital, Denmark

    collaborator OTHER
  • Aarhus University Hospital

    lead OTHER

Principal Investigators

  • Jens C Nielsen, prof., DMSc, · Department of Cardiology, Aarhus University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-05-31
Primary Completion
2023-03-31
Completion
2023-03-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02034526 on ClinicalTrials.gov